Related references
Note: Only part of the references are listed.AACE Comprehensive Diabetes Management Algorithm 2013
Alan Garber et al.
Endocrine Practice (2015)
Patient Perspectives on Discharge from Specialist Type 2 Diabetes Care Back to Primary Care: A Qualitative Study
Heidi Dutton et al.
CANADIAN JOURNAL OF DIABETES (2014)
Glycemic Variability in Patients With Early Type 2 Diabetes: The Impact of Improvement in β-Cell Function
Caroline K. Kramer et al.
DIABETES CARE (2014)
Liraglutide reverses pronounced insulin-associated weight gain, improves glycaemic control and decreases insulin dose in patients with type 2 diabetes: a 26 week, randomised clinical trial (ELEGANT)
Helena M. de Wit et al.
DIABETOLOGIA (2014)
Hope and fear for new classes of type 2 diabetes drugs: is there preclinical evidence that incretin-based therapies alter pancreatic morphology?
Benjamin J. Lamont et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Determinants of reversibility of β-cell dysfunction in response to short-term intensive insulin therapy in patients with early type 2 diabetes
Caroline Kaercher Kramer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Specific actions of GLP-1 receptor agonists and DPP4 inhibitors for the treatment of pancreatic β-cell impairments in type 2 diabetes
Stephane Dalle et al.
CELLULAR SIGNALLING (2013)
Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial
Markolf Hanefeld et al.
CURRENT DIABETES REPORTS (2013)
Individualized glycaemic targets and pharmacotherapy in type 2 diabetes
Clifford J. Bailey et al.
DIABETES & VASCULAR DISEASE RESEARCH (2013)
Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings
J. J. Holst et al.
DIABETES OBESITY & METABOLISM (2013)
Does the shortage of diabetes specialists in regional and rural Australia matter? Results from Diabetes MILES-Australia
Timothy Skinner et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
Short-Term Continuous Subcutaneous Insulin Infusion Combined with Insulin Sensitizers Rosiglitazone, Metformin, or Antioxidant α-Lipoic Acid in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Zhimin Huang et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2013)
Clinical Evidence for the Earlier Initiation of Insulin Therapy in Type 2 Diabetes
David R. Owens
DIABETES TECHNOLOGY & THERAPEUTICS (2013)
Fasting plasma glucose after intensive insulin therapy predicted long-term glycemic control in newly diagnosed type 2 diabetic patients
Jianbin Liu et al.
ENDOCRINE JOURNAL (2013)
The Effect of Early Intensive Insulin Therapy on Body Fat Distribution and beta-Cell Function in Newly Diagnosed Type 2 Diabetes
Jang Won Son et al.
ENDOCRINE RESEARCH (2013)
Current role of short-term intensive insulin strategies in newly diagnosed type 2 diabetes
Wen Xu et al.
JOURNAL OF DIABETES (2013)
Patients newly diagnosed with clinical type 2 diabetes mellitus but presenting with HbA1c within normal range: 19-Year mortality and clinical outcomes
A. G. Veloso et al.
PRIMARY CARE DIABETES (2013)
Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis
Caroline Kaercher Kramer et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy
Lindsay B. Harrison et al.
DIABETES CARE (2012)
Attitudes Toward Diabetes Affect Maintenance of Drug-Free Remission in Patients With Newly Diagnosed Type 2 Diabetes After Short-Term Continuous Subcutaneous Insulin Infusion Treatment
Ailing Chen et al.
DIABETES CARE (2012)
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi et al.
DIABETES CARE (2012)
Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis
C. F. Deacon et al.
DIABETES OBESITY & METABOLISM (2012)
Short-term intensified insulin treatment in type 2 diabetes: long-term effects on β-cell function
R. Retnakaran et al.
DIABETES OBESITY & METABOLISM (2012)
Increased 1,5-Anhydroglucitol Predicts Glycemic Remission in Patients with Newly Diagnosed Type 2 Diabetes Treated with Short-Term Intensive Insulin Therapy
Liehua Liu et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2012)
Effects of a combination of oral anti-diabetes drugs with basal insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes
Pan-wei Mu et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2012)
Effect of short-term intensive insulin therapy on quality of life in type 2 diabetes
Christine Opsteen et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2012)
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
Juris J. Meier
NATURE REVIEWS ENDOCRINOLOGY (2012)
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor-based electronic health record
Emily S. Brouwer et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Are patients with type 2 diabetes reluctant to start insulin therapy? An examination of the scope and underpinnings of psychological insulin resistance in a large, international population
William H. Polonsky et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Short-Term Intensive Therapy in Newly Diagnosed Type 2 Diabetes Partially Restores Both Insulin Sensitivity and β-Cell Function in Subjects With Long-Term Remission
Yun Hu et al.
DIABETES CARE (2011)
IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
David R. Whiting et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Recovery of β-Cell Functions with Low-Dose Insulin Therapy: Study in Newly Diagnosed Type 2 Diabetes Mellitus Patients
Saptarshi Bhattacharya et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Bariatric surgery: an IDF statement for obese Type 2 diabetes
J. B. Dixon et al.
DIABETIC MEDICINE (2011)
A quantitative assessment of patient barriers to insulin
R. Casciano et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Could We Use Clinical Benefit to Evaluate the Effects of Chinese Medicine on the Treatment of Cancer?
Li Ping-ping
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2010)
Secondary Failure of Metformin Monotherapy in Clinical Practice
Jonathan B. Brown et al.
DIABETES CARE (2010)
Cost-Effectiveness of Bariatric Surgery for Severely Obese Adults With Diabetes
Thomas J. Hoerger et al.
DIABETES CARE (2010)
The response to short-term intensive insulin therapy in type 2 diabetes
R. Retnakaran et al.
DIABETES OBESITY & METABOLISM (2010)
Initial short-term intensive insulin therapy as a strategy for evaluating the preservation of beta-cell function with oral antidiabetic medications: a pilot study with sitagliptin
R. Retnakaran et al.
DIABETES OBESITY & METABOLISM (2010)
Targeting beta-Cell Function Early in the Course of Therapy for Type 2 Diabetes Mellitus
Jack L. Leahy et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
The Effect of Early Insulin Therapy on Pancreatic β-Cell Function and Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients
Suk Chon et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2010)
Functional pancreatic beta-cell mass: Involvement in type 2 diabetes and therapeutic intervention
M. Karaca et al.
DIABETES & METABOLISM (2009)
Early Insulin Use in Type 2 Diabetes What are the cons?
Jean-Louis Chiasson
DIABETES CARE (2009)
Cost-Effectiveness of Surgically Induced Weight Loss for the Management of Type 2 Diabetes: Modeled Lifetime Analysis
Catherine L. Keating et al.
DIABETES CARE (2009)
Early Insulin Treatment in Type 2 Diabetes What are the pros?
Luigi F. Meneghini
DIABETES CARE (2009)
Insulin-Based Versus Triple Oral Therapy for Newly Diagnosed Type 2 Diabetes Which is better?
Ildiko Lingvay et al.
DIABETES CARE (2009)
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation
J. Picot et al.
HEALTH TECHNOLOGY ASSESSMENT (2009)
Pro's and Con's of the early use of insulin in the management of type 2 diabetes: a clinical evaluation
Mayer B. Davidson
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2009)
Beneficial Effects of Insulin on Glycemic Control and β-Cell Function in Newly Diagnosed Type 2 Diabetes With Severe Hyperglycemia After Short-Term Intensive Insulin Therapy
Harn-Shen Chen et al.
DIABETES CARE (2008)
Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes:: a 4-year follow-up
M. Alvarsson et al.
DIABETES OBESITY & METABOLISM (2008)
Beta cells in type 2 diabetes - a crucial contribution to pathogenesis
Kathrin Maedler
DIABETES OBESITY & METABOLISM (2008)
Comparison of gliclazide with insulin as initial treatment modality in newly diagnosed type 2 diabetes
Satish T. Chandra et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2008)
Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes:: a multicentre randomised parallel-group trial
Jianping Weng et al.
LANCET (2008)
Efficacy and safety of incretin therapy in type 2 diabetes - Systematic review and meta-analysis
Renee E. Amori et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Insulin as initial therapy in type 2 diabetes: Effective, safe, and well accepted
Ildiko Lingvay et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2007)
The significance of tumor necrosis factor-α in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment
Haibing Chen et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Steven E. Kahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Five stages of evolving β-cell dysfunction during progression to diabetes
GC Weir et al.
DIABETES (2004)
Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of β-cell function
YB Li et al.
DIABETES CARE (2004)
Beta- and alpha-cell dysfunction in type 2 diabetes
S Del Prato et al.
HORMONE AND METABOLIC RESEARCH (2004)
Short-term intensive insulin therapy in newly diagnosed type 2 diabetes
EA Ryan et al.
DIABETES CARE (2004)
Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients
M Alvarsson et al.
DIABETES CARE (2003)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Share Paper
